Signal Bioscience
- | Diagnostics
Signal Bioscience is a Life ScienceTools company developing novel reagents to dramatically extend the capabilities of existing molecular diagnostic instruments.
PCR (polymerase chain reaction) tests are a workhorse in Molecular Biology & Diagnostics, with over 2 Billion tests run per year globally. Our patent pending reagents make PCR instruments faster, more sensitive, and higher throughput. We plan to work with existing industry players for development partnerships & commercialization, beginning with r dPCR (digital PCR). Our reagents will allow dPCR assays to multiplex up to 100 targets/assay, enabling dPCR to perform clinical assays now conventionally run by NGS (Next Generation Sequencing.)
Our CSO was a co-founder of Rubicon Genomics (Takara) & Swift Bioscience (IDT). Our CBO was Director of Strategy for Thermo Fisher’s PCR reagent business. Our CEO ran a high throughput clinical diagnostics lab. We are planning for a Series A round in H2 2025. We are located in Ann Arbor, MI.
Address
Ann ArborMichigan
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}